EPISODE · Apr 25, 2024 · 11 MIN
Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications
from Arthritis At Home (+ On the Go) · host Arthritis Consumer Experts
In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Derin Karacabeyli, rheumatology resident at the University of British Columbia. Dr. Karacabeyli is studying the effects of treating metabolic comorbidities like obesity and type 2 diabetes on patients with immune-mediated inflammatory diseases. In this interview, he shares the work he is conducting to look at the potential risks and benefits for inflammatory arthritis patients taking a new class of medications used in type 2 diabetes therapy.Additional learning resourcesMore information about GLP-1 AgonistsMore information about SGLT-2 inhibitorsThe Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review
Embed this episode
What this episode covers
In this episode of Arthritis At Home, we are sharing the #CRArthritis interview with Dr. Derin Karacabeyli, rheumatology resident at the University of British Columbia. Dr. Karacabeyli is studying the effects of treating metabolic comorbidities like obesity and type 2 diabetes on patients with immune-mediated inflammatory diseases. In this interview, he shares the work he is conducting to look at the potential risks and benefits for inflammatory arthritis patients taking a new class of medica...
Ready to play
Incidence of autoimmune rheumatic diseases following exposure to diabetes and weight loss medications
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.